Strategic Acquisition Avitide is a Repligen Company with established affinity purification capabilities and ISO 9001:2015 quality management, indicating strong alignment with industrial biopharma manufacturing needs and potential cross-sell or upsell opportunities within Repligen’s customer base.

Fast Delivery Advantage The 3-month concept-to-resin delivery timeline can be pitched to biopharma sponsors and CDMOs seeking accelerated development timelines, enabling faster process development, scalability, and potential engagement for next-generation continuous downstream processing projects.

Diverse Molecule Coverage Avitide supports a broad range of biologics and therapies (enzymes, antibodies, cell therapies, vaccines, gene therapy vectors), suggesting cross-selling of affinity solutions to companies pursuing multiple modalities and complex biologics pipelines.

Integrated with Repligen As part of Repligen, Avitide can be positioned for bundled solutions with upstream/downstream platforms, leveraging existing customer relationships and expanding into end-to-end purification and resin supply contracts.

Global Quality & Continuity Proven supply continuity and quality systems under ISO 9001:2015, with a track record of audits, presenting a low-risk supplier profile suitable for strategic partnerships, preferred supplier lists, and long-term resin procurement deals.